Pw. Grigsby et al., FDG-PET evaluation of recurrent endometrial carcinoma, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 73-77
Positron emission tomography (PET) with the glucose analogue 2[F-18]fluoro-
2-deoxy-D-glucose (FDG) has been used to evaluate a variety of cancers. We
evaluated the use of FDG-PET in patients with suspected recurrent carcinoma
of the endometrium and compared the results of FDG-PET with those of conve
ntional imaging studies.
Our results suggest that FDG-PET is a sensitive method for detecting vagina
l apex recurrences greater than 1 cm in diameter and metastatic lesions fro
m carcinoma of the endometrium.